Login / Signup

Prevalence and breakdown of EGFR exon 20 driver mutations in routine NHS lung cancer diagnostic testing.

David Allan MooreKevin Jon BalbiBenjamin PoskittPhilip Bennett
Published in: Journal of clinical pathology (2021)
Keyphrases
  • small cell lung cancer
  • epidermal growth factor receptor
  • risk factors
  • patient safety
  • tyrosine kinase
  • clinical practice
  • quality improvement